A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...

VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

The FDA has granted Priority Review to a supplemental biologics license application for Vyvgart, targeting broader use in myasthenia gravis. The review focuses on expanding Vyvgart’s label to reach a ...

In 2021, Jax was diagnosed with IPEX syndrome, an extremely rare condition that only impacts one in every 1.6 million people.

Investing.com -- The biotechnology sector continues to offer compelling investment opportunities in 2026, with several companies poised for significant growth according to Bank of America analysts.

I’ve long been accused of having RBF, or resting bitch face. Even before I experienced the natural lines of aging, which ...

If your chronic inflammatory demyelinating polyneuropathy (CIDP) treatment has hit a plateau, new options like FcRn ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...

A 4-week-old baby girl came into the emergency room because she’d been fussy for a full day, and wouldn’t drink from her bottle. On further questioning, the parents said that she had not pooped for 3 ...